866-997-4948 (US-Canada Toll Free)

Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published By :

Transparency

Published Date : 2013-12-20

Category :

Medical Equipments

No. of Pages : 105

Product Synopsis

Orthobiology is a branch of science that develops bone and tissue replacement materials for skeletal and tissue healing. Orthobiologics has been gaining popularity since it provides accelerated healing, faster recovery and reduction in number of hospital visits. A rise in the incidence of arthritis and geriatric population has triggered the growth of this market. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and rising participation in sports related activities has considerably augmented the growth of this market.

The research report on orthobiologics provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of orthobiologics on the basis of different orthobiologic products and applications. The product segment comprises allografts, demineralized bone matrix (DBM), bone morphogenetic proteins (BMPs), viscosupplementation, synthetic bone graft substitutes, stem cell based products and machined bone. The application segment is classified into spinal fusion, trauma and reconstructive surgeries. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments, in terms of USD million, using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.

The market has also been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW), and the respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global orthobiologics market, and future opportunities has been provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter’s five force analysis for the orthobiologics market.

The market players are profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Medtronic, Inc., Stryker Corporation., DePuySythes, Wright Medical Technology, Inc., NuVasive, Inc., Orthofix, Inc., and others.
The global orthobiologicsmarket is segmented into the following categories:

OrthobiologicsMarket, by Products
  • Allografts
  • Machined Bones
  • Demineralized Bone Matrix (DBM)
  • Bone Morphogenetic Proteins (BMPs)
  • Viscosupplementation
  • Stem Cell Therapy
  • Synthetic Bone Substitutes
OrthobiologicsMarket, by Applications
  • Spinal Fusion
  • Trauma
  • Reconstructive Surgery
Orthobiologics Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • RoW

Table Of Content

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
2.2 Global Orthobiologics Market, by Products, 2012 (USD Million)
2.3 Global Orthobiologics Market, by Applications, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Drivers
3.1.1.1 Rising prevalence of chronic arthritis and rapidly aging world population
3.1.1.2 Surge in sports injuries
3.1.1.3 Surge in the number of orthopedic surgeries
3.1.1.4 Technological advances in bone graft materials to boost market growth
3.1.1.5 Demand for innovative products to bolster the growth of the market
3.1.2 Restraints
3.1.2.1 Lack of Reimbursement
3.1.2.2 Stringent regulatory requirements to restrain market growth
3.1.3 Opportunities
3.1.3.1 Rise in cell based matrices
3.1.3.2 Emerging markets
3.2 Porter’s Five Force Analysis: Global Orthobiologics Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Orthobiologics Market, by Geography

Chapter 4 Global Orthobiologics Market, by Product
4.1 Overview
4.1.1 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
4.2 Bone Morphogenetic Proteins
4.2.1 Global Bone Morphogenetic Proteins Product Market, 2011 – 2019 (USD Million)
4.3 Demineralized Bone Matrix (DBM)
4.3.1 Global Demineralized Bone Matrix Product Market, 2011 – 2019 (USD Million)
4.4 Synthetic Bone Substitutes
4.4.1 Global Synthetic Bone Substitutes Product Market, 2011 – 2019 (USD Million)
4.5 Viscosupplementation
4.5.1 Global Viscosupplementation Product Market, 2011 – 2019 (USD Million)
4.6 Allograft
4.6.1 Global Allografts Product Market, 2011 – 2019 (USD Million)
4.7 Stem Cell Therapy
4.7.1 Global Stem Cell Therapy Product Market, 2011 – 2019 (USD Million)
4.8 Machined Bones
4.8.1 Global Machined Bones Product Market, 2011 – 2019 (USD Million)

Chapter 5 Global Orthobiologics Market, by Application
5.1 Overview
5.1.1 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Spinal Fusion
5.2.1 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
5.3 Trauma
5.3.1 Global Trauma Application Market, 2011 – 2019 (USD Million)
5.4 Reconstructive surgery
5.4.1 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)

Chapter 6 Global Orthobiologics Market, by Geography
6.1 Overview
6.1.1 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
6.3.1 North America Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.3.2 North America Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.4 Europe
6.4.1 Europe Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.4.2 Europe Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia-Pacific Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.5.2 Asia-Pacific Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.6 RoW
6.6.1 RoW Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.6.2 RoW Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

Chapter 7 Global Orthobiologics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Orthobiologics Market
7.1.1 Global Orthobiologics Market Share Analysis, by Key Players, 2012 (%)

Chapter 8 Recommendations
8.1 Success strategies
8.1.1 Rigorous research and development (R&D) initiatives
8.1.2 Investing in emerging economies
8.2 Barriers to be considered
8.2.1 Significant Cost of Investment

Chapter 9 Company Profiles
9.1 Alphatec Spine, Inc.
9.1.1 Business Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Bacterin International, Inc.
9.2.1 Business Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Biomet, Inc.
9.3.1 Business overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 DePuy Synthes, Inc. (A Johnson & Johnson Company)
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Exactech, Inc.
9.5.1 Business Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Globus Medical, Inc.
9.6.1 Business Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Integra LifeSciences Corporation
9.7.1 Business Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Medtronic, Inc.
9.8.1 Business Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 NuVasive, Inc.
9.9.1 Business Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Orthofix Holdings, Inc.
9.10.1 Business Overview
9.10.2 Financial Overview
9.10.3 Products Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Regeneration Technologies, Inc.
9.11.1 Business Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Sanofi
9.12.1 Business Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Stryker Corporation
9.13.1 Business Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.13.5 Recent Developments
9.14 Wright Medical Technology, Inc.
9.14.1 Business Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments
9.15 Zimmer Holdings, Inc.
9.15.1 Business Overview
9.15.2 Financial Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies
9.15.5 Recent Developments

List of Tables

TABLE 1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
TABLE 2 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 3 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 4 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
TABLE 5 North America Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 6 North America Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Europe Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 8 Europe Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 9 Asia-Pacific Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 11 RoW Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 12 RoW Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Orthobiologics: Market Segmentation
FIG. 2 Global Orthobiologics Market, by Products, 2012 (USD Million)
FIG. 3 Global Orthobiologics Market, by Application, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Orthobiologics Market
FIG. 5 Market Attractiveness Analysis: Global Orthobiologics Market, by Geography
FIG. 6 Global Bone Morphogenetic Protein Products, 2011 – 2019 (USD Million)
FIG. 7 Global Demineralized Bone Matrix Products, 2011 – 2019 (USD Million)
FIG. 8 Global Synthetic Bone Substitute Products, 2011 – 2019 (USD Million)
FIG. 9 Global Viscosupplementation Products, 2011 – 2019 (USD Million)
FIG. 10 Global Allograft Products, 2011 – 2019 (USD Million)
FIG. 11 Global Stem Cell Therapy Products, 2011 – 2019 (USD Million)
FIG. 12 Global Machined Bone Products, 2011 – 2019 (USD Million)
FIG. 13 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
FIG. 14 Global Trauma Application Market, 2011 – 2019 (USD Million)
FIG. 15 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)
FIG. 16 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
FIG. 17 Global Orthobiologics: Market Share, by Key Players, 2012 (%)
FIG. 18 Alphatec Spine, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Bacterin International Holdings, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 20 Biomet, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Johnson & Johnson, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Exactech, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Globus Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Integra LifeSciences Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 NuVasive, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Orthofix Holdings, Inc., Annual Revenue: 2010-2012 (USD Million)
FIG. 28 Regeneration Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Sanofi, Annual Revenue: 2010 – 2012 (USD Million) (1 Euro= 1.31 USD)
FIG. 30 Stryker Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Wright Medical Technology, Inc.: Annual Revenue 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc, Annual Revenue: 2010 – 2012 (USD Million)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Automotive Cockpit Electronics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    By - Transparency

    Electronics in automotive industry has increased ease of driving, safety and also vies to provide quality infotainment. Automotive electronics industry provides solutions for perfect combination of design, feel, ergonomics and quality through electronics. The solutions provided include instrument clusters, displays, infotainment & navigation, and telematics. Cockpit electronics has a large market and has seen a high growth rate in recent times. This trend in growth for automotive cockpit electronics market is expected to continue over the coming years. Regionally, North America...

  • Solid State Drive (SSD) Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2014 - 2020

    By - Transparency

    A solid-state drive (SSD) is also known as an electronic disk or solid-state disk, is a data storage device, that is built out of semiconductors. SSD uses same input/output interfaces designed and developed for HDD (Hard Disk Drives) and uses solid state memory to store persistent data. Solid-state drive doesn’t have moving mechanical components and uses DRAM to store data or NAND based flash memory. It can be classified into two types namely flash memory based SSDs and DRAM-based SSDs. Flash memory based SSDs do not require batteries and use non-volatile flash memory. In addition,...

  • Epichlorohydrin Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

    By - Transparency

    Epichlorohydrin (ECH) is an organochlorine compound and an epoxide. It contains an organic compound having at least one chlorine covalent bond and cyclic ether rings. This is the compound mainly used for the production of epoxy resins which are used in coating, adhesives, and plastics. However, it is also used in manufacturing commercial pesticides. There are several other applications of epichlorohydrin as well. The epichlorohydrin market is expected to show growth in the coming future because of the increasing variety of uses in different product manufacturing processes....